Gexin Zhao

1.6k total citations
34 papers, 1.1k citations indexed

About

Gexin Zhao is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Gexin Zhao has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Immunology. Recurrent topics in Gexin Zhao's work include Viral-associated cancers and disorders (5 papers), Cytomegalovirus and herpesvirus research (4 papers) and Single-cell and spatial transcriptomics (3 papers). Gexin Zhao is often cited by papers focused on Viral-associated cancers and disorders (5 papers), Cytomegalovirus and herpesvirus research (4 papers) and Single-cell and spatial transcriptomics (3 papers). Gexin Zhao collaborates with scholars based in China, United States and Russia. Gexin Zhao's co-authors include Ming‐Jiang Xu, Xian Wang, Youfei Guan, Wei Kong, Xiaofeng Mu, Yan Cai, Chaoshu Tang, Mingming Zhao, Xiaoyan Dai and Anton Buzdin and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Gexin Zhao

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gexin Zhao China 16 477 252 199 171 170 34 1.1k
Rangnath Mishra United States 19 767 1.6× 186 0.7× 128 0.6× 138 0.8× 119 0.7× 40 1.4k
Zhengzhe Li China 19 471 1.0× 117 0.5× 359 1.8× 155 0.9× 110 0.6× 33 1.1k
Yael Nechemia‐Arbely United States 13 716 1.5× 107 0.4× 145 0.7× 82 0.5× 208 1.2× 17 1.2k
Rongqing Guo United States 8 816 1.7× 450 1.8× 221 1.1× 231 1.4× 142 0.8× 9 1.4k
Yumi Takiyama Japan 21 584 1.2× 218 0.9× 174 0.9× 151 0.9× 251 1.5× 48 1.4k
Hongfei Ji China 21 664 1.4× 335 1.3× 78 0.4× 248 1.5× 308 1.8× 60 1.3k
Xi Tang China 22 972 2.0× 388 1.5× 192 1.0× 175 1.0× 562 3.3× 53 1.6k
Minseob Eom South Korea 14 352 0.7× 172 0.7× 104 0.5× 69 0.4× 121 0.7× 45 797
Óscar López‐Franco Spain 24 601 1.3× 317 1.3× 186 0.9× 608 3.6× 227 1.3× 40 1.6k

Countries citing papers authored by Gexin Zhao

Since Specialization
Citations

This map shows the geographic impact of Gexin Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gexin Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gexin Zhao more than expected).

Fields of papers citing papers by Gexin Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gexin Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gexin Zhao. The network helps show where Gexin Zhao may publish in the future.

Co-authorship network of co-authors of Gexin Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Gexin Zhao. A scholar is included among the top collaborators of Gexin Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gexin Zhao. Gexin Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Cong, Guo‐Long Bu, Chu Xie, et al.. (2025). Structural basis of Epstein-Barr virus gp350 receptor recognition and neutralization. Cell Reports. 44(1). 115168–115168. 6 indexed citations
2.
Bu, Guo‐Long, et al.. (2025). Optimizing mRNA translation efficiency through rational 5′UTR and 3′UTR combinatorial design. Gene. 942. 149254–149254. 3 indexed citations
3.
Li, Shuxin, Qiao-Li Wang, Guohui Wan, et al.. (2024). Formyl peptide enhances cancer immunotherapy by activating antitumoral neutrophils, and T cells. Biomedicine & Pharmacotherapy. 175. 116670–116670. 2 indexed citations
4.
Zhao, Gexin, Guo‐Long Bu, Cong Sun, et al.. (2024). Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection. Cell Reports Medicine. 5(5). 101573–101573. 4 indexed citations
5.
Wang, Ye, Bin Liu, Gexin Zhao, et al.. (2023). Spatial transcriptomics: Technologies, applications and experimental considerations. Genomics. 115(5). 110671–110671. 91 indexed citations
6.
Zhao, Gexin, et al.. (2022). Ajuba Overexpression Promotes Breast Cancer Chemoresistance and Glucose Uptake through TAZ‐GLUT3/Survivin Pathway. BioMed Research International. 2022(1). 3321409–3321409. 9 indexed citations
7.
Ding, Xili, Yang Song, Jing Wang, et al.. (2022). Distinct patterns of responses in endothelial cells and smooth muscle cells following vascular injury. JCI Insight. 7(20). 9 indexed citations
8.
Wang, Ye, Zhuang Tong, Wen‐Hua Zhang, et al.. (2021). FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients. Frontiers in Oncology. 11. 683419–683419. 142 indexed citations
9.
Zhao, Gexin, Elliot W. Kim, Jie Jiang, et al.. (2020). CCN1/Cyr61 Is Required in Osteoblasts for Responsiveness to the Anabolic Activity of PTH. Journal of Bone and Mineral Research. 35(11). 2289–2300. 7 indexed citations
10.
Wang, Ye, Zhuang Tong, Xiaofeng Mu, et al.. (2020). Changing Technologies of RNA Sequencing and Their Applications in Clinical Oncology. Frontiers in Oncology. 10. 447–447. 71 indexed citations
11.
Hu, Kejia, Amy J. Wang, Gexin Zhao, et al.. (2019). Spine surgeon specialty differences in single-level percutaneous kyphoplasty. BMC Surgery. 19(1). 163–163. 6 indexed citations
12.
Zhao, Gexin, Bau‐Lin Huang, Diana Rigueur, et al.. (2018). CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance. Journal of Bone and Mineral Research. 33(6). 1076–1089. 32 indexed citations
13.
Jiang, Jie, Gexin Zhao, & Karen M. Lyons. (2018). Characterization of bone morphology in CCN5/WISP5 knockout mice. Journal of Cell Communication and Signaling. 12(1). 265–270. 8 indexed citations
14.
Zhang, Yihan, Haigen Huang, Gexin Zhao, et al.. (2017). ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13. PLoS Genetics. 13(2). e1006481–e1006481. 45 indexed citations
15.
Chen, Beidong, Meng Li, Tao Shen, et al.. (2017). Thioredoxin attenuates oxidized low-density lipoprotein induced oxidative stress in human umbilical vein endothelial cells by reducing NADPH oxidase activity. Biochemical and Biophysical Research Communications. 490(4). 1326–1333. 18 indexed citations
16.
Zhao, Yang, Xiaoyan Dai, Zhou Zhou, et al.. (2015). Leucine supplementation via drinking water reduces atherosclerotic lesions in apoE null mice. Acta Pharmacologica Sinica. 37(2). 196–203. 31 indexed citations
17.
Shen, Tao, Yuping Zhu, J. Patel, et al.. (2013). T-Box20 Suppresses Oxidized Low-Density Lipoprotein-induced Human Vascular Endothelial Cell Injury by Upregulation of PPAR-γ. Cellular Physiology and Biochemistry. 32(5). 1137–1150. 12 indexed citations
18.
Zhao, Gexin, et al.. (2012). Ginkgolide B Reduces Atherogenesis and Vascular Inflammation in ApoE−/− Mice. PLoS ONE. 7(5). e36237–e36237. 36 indexed citations
19.
Zhao, Mingming, Ming‐Jiang Xu, Yan Cai, et al.. (2011). Mitochondrial reactive oxygen species promote p65 nuclear translocation mediating high-phosphate-induced vascular calcification in vitro and in vivo. Kidney International. 79(10). 1071–1079. 181 indexed citations
20.
Wang, Chengzhi, Xiaoqing Ma, Donghui Yang, et al.. (2010). Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria. BMC Microbiology. 10(1). 115–115. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026